AbstractThe N-Acetylglucosaminyl-1-phosphotransferase plays a key role in the generation of mannose 6-phosphate (M6P) recognition markers essential for efficient transport of lysosomal hydrolases to lysosomes. The phosphotransferase is composed of six subunits (α2, β2, γ2). The α- and β-subunits are catalytically active and encoded by a single gene, GNPTAB, whereas the γ-subunit encoded by GNPTG is proposed to recognize conformational structures common to lysosomal enzymes. Defects in GNPTG cause mucolipidosis type III gamma, which is characterized by missorting and cellular loss of lysosomal enzymes leading to lysosomal accumulation of storage material. Using plasmon resonance spectrometry, we showed that recombinant γ-subunit failed to bi...
Mucolipidosis (ML) II and MLIII alpha/beta are two pediatric lysosomal storage disorders caused by m...
UDP-GlcNAc:lysosomal enzyme N-acetylglucosamine-1-phosphotransferase is an α2β2γ2 hexameric enzyme t...
Mucopolysaccharidosis (MPS) I is a lysosomal storage disease caused by a deficiency of α-L-iduronida...
AbstractThe N-Acetylglucosaminyl-1-phosphotransferase plays a key role in the generation of mannose ...
Mucolipidosis II (MLII; I-cell disease) and mucolipidosis IIIA (MLIIIA; classical pseudo-Hurler poly...
Lysosomal hydrolases catalyze the degradation of a variety of macromolecules including proteins, car...
GlcNAc-1-phosphotransferase catalyzes the transfer of a GlcNAc-1-phosphate residue from UDP-GlcNAc ...
AbstractThe lysosomal storage disorders are a group of inherited metabolic diseases each characteris...
Mucolipidosis II (MLII; I-cell disease) and mucolipidosis IIIA (MLIIIA; classical pseudo-Hurler poly...
Mucolipidosis II (ML II) and mucolipidosis III (ML III) are diseases in which the activity of the ur...
Mucopolysaccharidosis IIIC (MPS IIIC), or Sanfilippo C, represents the only MPS disorder in which th...
Disruption of the mannose 6-phosphate (M-6-P) pathway in HeLa cells by inactivation of the GNPTAB ge...
Mutations in the GNPTAB and GNPTG genes cause mucolipidosis (ML) type II, type III alpha/beta, and t...
To accomplish their degradative function lysosomes must be filled with specific proteins, which afte...
Mucopolysaccharidosis IIIC (MPS IIIC, or Sanfilippo C syndrome) is a lysosomal storage disorder caus...
Mucolipidosis (ML) II and MLIII alpha/beta are two pediatric lysosomal storage disorders caused by m...
UDP-GlcNAc:lysosomal enzyme N-acetylglucosamine-1-phosphotransferase is an α2β2γ2 hexameric enzyme t...
Mucopolysaccharidosis (MPS) I is a lysosomal storage disease caused by a deficiency of α-L-iduronida...
AbstractThe N-Acetylglucosaminyl-1-phosphotransferase plays a key role in the generation of mannose ...
Mucolipidosis II (MLII; I-cell disease) and mucolipidosis IIIA (MLIIIA; classical pseudo-Hurler poly...
Lysosomal hydrolases catalyze the degradation of a variety of macromolecules including proteins, car...
GlcNAc-1-phosphotransferase catalyzes the transfer of a GlcNAc-1-phosphate residue from UDP-GlcNAc ...
AbstractThe lysosomal storage disorders are a group of inherited metabolic diseases each characteris...
Mucolipidosis II (MLII; I-cell disease) and mucolipidosis IIIA (MLIIIA; classical pseudo-Hurler poly...
Mucolipidosis II (ML II) and mucolipidosis III (ML III) are diseases in which the activity of the ur...
Mucopolysaccharidosis IIIC (MPS IIIC), or Sanfilippo C, represents the only MPS disorder in which th...
Disruption of the mannose 6-phosphate (M-6-P) pathway in HeLa cells by inactivation of the GNPTAB ge...
Mutations in the GNPTAB and GNPTG genes cause mucolipidosis (ML) type II, type III alpha/beta, and t...
To accomplish their degradative function lysosomes must be filled with specific proteins, which afte...
Mucopolysaccharidosis IIIC (MPS IIIC, or Sanfilippo C syndrome) is a lysosomal storage disorder caus...
Mucolipidosis (ML) II and MLIII alpha/beta are two pediatric lysosomal storage disorders caused by m...
UDP-GlcNAc:lysosomal enzyme N-acetylglucosamine-1-phosphotransferase is an α2β2γ2 hexameric enzyme t...
Mucopolysaccharidosis (MPS) I is a lysosomal storage disease caused by a deficiency of α-L-iduronida...